After Sanofi’s setbacks, Takeda eyes finish line with its dengue vaccine

Takeda has revealed long-term clinical trial results with its dengue vaccine that reinforce its safety and efficacy – and help to differentiate it from Sanofi’s challenged Dengvaxia shot.